We have addressed the effect of HGF, and subsequent inhibition of c-MET, on migration of ovarian cancer cells in both directional (chemotactic) and random migration assays, to more accurately recapitulate the environment and proteins encountered in an in vivo setting. The gene discussed is HGF; the disease is ovarian cancer.